Notably, KLF9 contributes to cancer development in other malignancies, such as pancreatic cancer (54–56), prostate cancer (57), thyroid cancer (58–60), and bladder cancer (61–63). This evidence concerns the gene KLF9 and familial pancreatic carcinoma.